Effect of Infusion of 500 ml 5% Human Albumin on the Muscle Tissue Oxygen Pressure in Patients with Intermittent Claudication

  • A. M. Ehrly
  • H. Landgraf
  • K. Saeger-Lorenz
Conference paper

Abstract

The infusion of plasma protein solutions or colloidal plasma substitutes is a well-known therapy not only for volume deficiency, but also for cerebral and peripheral ischemic diseases [1]. Besides replacement of the volume, the improvement in flow properties of the blood explains the improvement of clinical symptoms associated with hypovolemic conditions such as shock [2]. In the case of ischemic disease such as chronic arterial occlusion, however, the clinical effectiveness of an isovolemic infusion is attributed solely to an improvement in the flow properties of the blood [3, 4]; under hemodilution, the cardiac output is also raised [5].

Keywords

Placebo Starch Ethyl Albumin Serotonin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Messmer, K., H. Schmid-Schönbein (eds.): Hemodihition. Theoretical basis and clinical application. Karger-Verlag, Basel (1972)Google Scholar
  2. 2.
    Gelin, L. E., B. Ingelman: Rheomacrodex - a new dextran solution for rheological treatment of impaired capillary flow. Acta Shir. Scand 122 (1961) 294–302Google Scholar
  3. 3.
    Zederfeldt, B.: Rheological disturbances and their treatment in clinical surgery. In: A. L.Copley (ed): Symposium and Biorheology. Pergamon Press (1963) pp 393–407Google Scholar
  4. 4.
    Rieger, H., W.Schoop, H. Schmid-Schönbein, R. Schneider, H.Malotta: Isovolemic hemodilution (IHD) in peripheral vascular occlusive disease (PVOD). Concepts, methods and preliminary results. Microvasc. Res. 13 (1977) 267CrossRefGoogle Scholar
  5. 5.
    Landgraf, H., A. M. Ehrly: Hämorheologische Wirkungen hypervolämischer Hämodilution mit Dextran 40 und HAES 200 bei Patienten mit arterieller Verschlußkrankheit. In: Ehrly, A.M. (Hrsg.): Therapie mit hämorheologisch wirksamen Substanzen. Zuckschwerdt-Verlag, München (1984) S. 138–144Google Scholar
  6. 6.
    Messmer, K., L.Görnand, E.Sinagowitz, L.Sunder-Plassmann, F.Jesch, M.Kessler: Local oxygen tension in tissue of different organs during limited normovolemic hemodilution. Bibl. Anat. 12, Karger-Verlag, Basel (1973) p 327Google Scholar
  7. 7.
    Hauss, J., K.Schönleben, H.-U.Spiegel: Therapiekontrolle durch Überwachung des Gewebe- pO2. Aktuelle Probleme in der Angiologie, Bd. 41, Huber-Verlag, Bern (1982)Google Scholar
  8. 8.
    Landgraf, H., A.M.Ehrly: Verhalten des Muskelgewebesauerstoffdrucks bei Patienten mit Claudicatio intermittens nach Placebo- respektive Kochsalz-Infusionen. In: Ehrly, A.M., J.Hauss, R.Huch (Hrsg.): Klinische Sauerstoffdruckmessung. MWP-Verlag, München (1985) S. 63–69Google Scholar
  9. 9.
    Ehrly, A.M., H.-J.Köhler, W.Schroeder, R.Müller: Sauerstoffdruckwerte im ischämischen Muskelgewebe von Patienten mit chronischen peripheren arteriellen Verschlußkrankheiten. Klin. Wschr. 53 (1975) 687PubMedCrossRefGoogle Scholar
  10. 10.
    Ehrly, A.M., W.Schroeder: Zur Pathophysiologic der chronischen arteriellen Verschlußerkrankung. I. Mikrozirkulatorische Blutverteilungsstörung in der Skelettmuskulatur. Herz/Kreislauf 11 (1979) 275Google Scholar
  11. 11.
    Ehrly, A.M.: New pathophysiological concept of ischemic diseases: Microcirculatory Blood Maldistribution (MBM) Bibl. Anat. 20 (1980) 456Google Scholar
  12. 12.
    Ehrly, A.M., H.Landgraf: Effects of muscle tissue oxygen tension in claudicants: infusions of 5% albumin versus 10% hydroxyethylstarch solution (200/0,5). Third World Congress for Microcirculation, Oxford 1984 (abstract)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • A. M. Ehrly
  • H. Landgraf
  • K. Saeger-Lorenz

There are no affiliations available

Personalised recommendations